34 Chapter 2 26. Bofill Rodriguez M, Lethaby A, Fergusson RJ. Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding. Cochrane Database Syst Rev. 2021;2:CD000329. 27. Clarke-Pearson DL, Geller EJ. Complications of hysterectomy. Obstet Gynecol. 2013;121(3):654-73. 28. James AH, Kouides PA, Abdul-Kadir R, Edlund M, Federici AB, Halimeh S, et al. Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel. Am J Obstet Gynecol. 2009;201(1):12 e1-8. 29. Knol HM, Bogchelman DH, Kluin-Nelemans HC, van der Zee AG, van der Meer J, Meijer K. Routine evaluation and treatment of unexplained menorrhagia: do we consider haemostatic disorders? Eur J Obstet Gynecol Reprod Biol. 2010;152(2):191-4. 30. Eising HP, Sanders YV, de Meris J, Leebeek FWG, Meijer K. Women prefer proactive support from providers for treatment of heavy menstrual bleeding: A qualitative study in adult women with moderate or severe Von Willebrand disease. Haemophilia. 2018;24(6):950-6. 31. Punt MC, Blaauwgeers MW, Timmer MA, Welsing PMJ, Schutgens REG, van Galen KPM. Reliability and Feasibility of the Self-Administered ISTH-Bleeding Assessment Tool. TH Open. 2019;3(4):e350-e5. 32. Care CoAH. Committee Opinion No.580: von Willebrand disease in women. Obstetrics Gynecology. 2013;2013 dec(6):1368-73.
RkJQdWJsaXNoZXIy MTk4NDMw